Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ
Closed
Oct 23, 2026
Day's Range
5.0152 wk Range
5.01Profile - PHAT - Phathom Pharmaceuticals, Inc.
Profile
Mic Code
XNGS
Sector
Healthcare
Industry
Biotechnology
Employees
371
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for gastrointestinal diseases. The company’s commercial portfolio centers on vonoprazan-based therapies, including VOQUEZNA for the relief of heartburn associated with non-erosive and erosive GERD and the healing and maintenance of erosive GERD in adults. It also markets VOQUEZNA DUAL PAK and VOQUEZNA TRIPLE PAK for the treatment of Helicobacter pylori infection in adults. Phathom Pharmaceuticals operates as a specialist in acid-related GI disorders, combining research, product development, and commercialization to address conditions that affect the digestive system.
Profile Details
Type
Common Stock
Address
100 Campus Drive
City
Florham Park
State
NJ
Zip
07932
Country
United States
Phone
877 742 8466
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
